The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.

The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

Nearly four dozen people in 18 states have been sickened in an expanding outbreak of salmonella food poisoning tied to ...

Moderna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The Trump administration's decision to halt a $258 million HIV vaccine research program has sparked widespread concern. This ...

A budget proposal for the US Department of Health and Human Services details extensive cuts to funding for the National ...

This story has been updated to reflect changes to US Centers for Disease Control and Prevention immunization schedules. The US Department of Health and Human Services, under Secretary Robert F ...

Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Centers for Disease Control and Prevention will ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

Here’s everything parents should know about the COVID-19 vaccines for pregnant women, including why it's still an important way to protect yourself and your baby. Should I get t ...